Pangce Medical was founded in Shanghai in 2019 with incubation and investment from HIT Intelligent Equipment (000584). As a new-generation provider of intelligent surgical solutions, its team studies common clinical characteristics of various diseases, explores unmet universal clinical demands, develops professional medical surgical robots and delivers systematic medical solutions.
The company’s business spans formal medical treatment and consumer healthcare sectors. Its product lineup includes hair transplant robots and puncture navigation systems for surgical operations. It owns HAIRO®, China’s first NMPA-approved hair transplant robot, as well as the Probo® prostate surgical navigation system. The enterprise supplies robotic devices and integrated systematic solutions to meet medical demands in medical aesthetics, oncology and other fields.